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Abstract
Efficient and stoichiometric expression of genes concatenated by bi- or multi-cistronic vectors has become an invaluable
tool not only in basic biology to track and visualize proteins in vivo, but also for vaccine development and in the clinics for
gene therapy. To adequately compare, in vivo, the effectiveness of two of the currently popular co-expression strategies -
the internal ribosome entry site (IRES) derived from the picornavirus and the 2A peptide from the foot-and-mouth disease
virus (FDMV) (F2A), we analyzed two locus-specific knock-in mouse lines co-expressing SRY-box containing gene 9 (Sox9) and
enhanced green fluorescent protein (EGFP) linked by the IRES (Sox9
IRES-EGFP) or the F2A (Sox9
F2A-EGFP) sequence. Both the
constructs expressed Sox9 and EGFP proteins in the appropriate Sox9 expression domains, with the IRES construct
expressing reduced levels of EGFP compared to that of the F2A. The latter, on the other hand, produced about 42.2% Sox9-
EGFP fusion protein, reflecting an inefficient ribosome ‘skipping’ mechanism. To investigate if the discrepancy in the
‘skipping’ process was locus-dependent, we further analyzed the FLAG3-Bapx1
F2A-EGFP mouse line and found similar levels of
fusion protein being produced. To assess if EGFP was hindering the ‘skipping’ mechanism, we examined another mouse line
co-expressing Bagpipe homeobox gene 1 homolog (Bapx1), Cre recombinase and EGFP (Bapx1
F2A-Cre-F2A-EGFP). While the
‘skipping’ was highly efficient between Bapx1 and Cre, the ‘skipping’ between Cre and EGFP was highly inefficient. We have
thus demonstrated in our comparison study that the efficient and close to equivalent expression of genes linked by F2A is
achievable in stable mouse lines, but the EGFP reporter may cause undesirable inhibition of the ‘skipping’ at the F2A
sequence. Hence, the use of other reporter genes should be explored when utilizing F2A peptides.
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Introduction
Advancement in cloning technologies has led to the construc-
tion of polycistronic vectors, which have been used for the co-
expression of multiple proteins from a single promoter for vaccine
production (antigen expression) [1], in vivo stable antibody
production [2], multimeric protein expression (e.g. T-cell receptor)
[3,4], cell tracking and enrichment [5,6] and even for reprogram-
ming human somatic cells to induced pluripotent stem (iPS) cells
[7].
Two of the most popular strategies that are employed to co-
express multiple genes in a single mRNA are the use of viral
internal ribosome entry site (IRES) sequence (internal cap-
independent initiation) and 2A oligopeptide sequences (cis-acting
hydrolase elements ‘‘CHYSEL’’) among many others such as
fusion proteins, post-translational enzymatic processing, alterna-
tive splicing, internal promoters and reinitiation [8].
Over the past two decades, IRES elements of viral and cellular
origins have been identified and the former (e.g. IRES from
encephalomyocarditis (EMCV) or poliovirus (PV)) has been
traditionally utilized in bi- and poly-cistronic vectors [9]. When
the IRES element is included between two open reading frames
(ORFs), initiation of translation occurs by the canonical 59-
m
7GpppN cap-dependent mechanism in the first ORF and a cap-
independent mechanism in the second ORF downstream of the
IRES element [10]. Although the exact processes mediating the
internal entry of ribosomes is unknown, it is largely believed that
the complex secondary structure adopted by the IRES-encoded
RNA sequence and/or the IRES-trans acting factors (ITAFs) are
responsible for the function of IRES [10,11]. Unlike the
reinitiation mechanism which is highly inefficient and the
alternative splicing method that is difficult to regulate for
application in multicistronic vectors, IRES enables successful co-
expression of the coupled genes. More importantly, it does not give
rise to fusion proteins which may adversely affect the activity of the
proteins [8]. Conversely, IRES is known for yielding lower
amounts of protein from the downstream genes and this
phenomenon is believed to exacerbate with increasing tandems;
an effect observed in a cell-type specific manner [8,10,12]. It is
postulated that such alterations in expression levels are due to the
varied requirements of the ITAFs for different IRESs and the
availability of different ITAFs in diverse cell types. Also, its large
size (,500 bp or more) often makes it an unattractive option for
use in viral vectors which have a limited packaging capacity [8,10].
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set of viral components, the 2A peptides, was identified in the foot-
and-mouth disease virus (FMDV) and later in other genera of
Picornaviridae family like the cardioviruses [13]. Also termed as
CHYSEL, these peptides ‘self-cleave’ their primary 2A/2B
polyproteins by a ribosomal ‘skipping’ mechanism which entails
inhibition of the peptide bond formation between the C-terminal
glycine residue of the 2A peptide and the N-terminal proline
residue of the 2B peptide [14]. Mutation analyses and alignment
studies on 2A/2B peptide sequences in various viruses such as the
EMCV, FMDV and Theiler’s murine encephalitis virus (TMEV)
have revealed an essential, consensus motif -DxExNPGQP- for
the ‘skipping’ function (Q represents the position of ‘skipping’)
[15]. This motif was also identified in type C rotaviruses, insect
viruses, repeated sequences in Trypanosoma species and in the
alpha-glucosiduronase protein of the hyperthermophilic bacterium
Thermotoga maritima. Of these, the bacterial sequence alone could
not give rise to discrete proteins from the concatenated genes,
indicating that the presence of the motif alone is insufficient for the
‘skipping’ mechanism [15]. Also, N-terminal extension of the
FMDV 2A (F2A) polyprotein, from 19 amino acids to 33 amino
acids, increased the ‘skipping’ efficiency from 90% to .99%,
proving that the upstream sequences are also instrumental to the
2A function [15].
This ‘skipping’ property of the 2A peptides has since been
exploited to construct multicistronic vectors and has recently
gained popularity over the IRES elements. When inserted between
two genes, after a ‘skip’ at the glycine-proline residues of 2A/2B,
the ribosome continues to translate the second gene thus
producing two discrete proteins. Their compactness (19–33 amino
acids) in length and their ability to allow the concatenated genes to
be translated at equivalent levels both in vitro and in vivo, have
served to complement the flaws in the IRES-based vectors.
Nonetheless, there are variations in the ‘skipping’ efficiency of the
2A peptides derived from different viruses (e.g. T2A of Thosea
asignavirus, P2A of Porcine teschovirus-1, F2A or E2A of Equine
rhinitis A virus) [16]. Moreover, differences in the ‘skipping’
efficiencies of the same 2A peptide in in vitro translation, in vivo cell
culture (including variation in different cell types) or animal
models, have been observed in numerous studies [2,4,6,17,18,19].
As no extensive investigation on the ‘skipping’ effectiveness of
these 2A peptides or a comparison of IRES vs. 2A in bi- or multi-
cistronic vectors has been performed in the mouse model in an
inheritable manner, we sought to assess if these aspects were
dependent on the context of the genes being linked in the
constructs.
In this study, by using the transcription factors (TFs) SRY-box
containing gene 9 (Sox9) and Bagpipe homeobox gene 1 homolog
(Bapx1) as examples, we have shown that both IRES and 2A
mediateco-expressionof these TFswithenhancedgreen fluorescent
protein (EGFP) and Cre recombinase when concatenated in bi- and
tri-cistronic vectors. As EGFP is one of the most commonly used
reporter proteins in mouse transgenics owing to its enhanced
photostability and strong fluorescence intensity [20,21,22], it is
necessary to study its compatibility with the IRES- and F2A-based
vector systems. Through the analysis of six locus-specific EGFP
knock-in mouse lines that we have generated – Sox9
IRES-EGFP,
Sox9
F2A-EGFP, FLAG3-Bapx1
F2A-EGFP, Bapx1
IRES-Cre-IRES-EGFP,
Bapx1
F2A-Cre-F2A-EGFP and Bapx1
EGFP (hereafter these mouse lines
will be denoted by their abbreviated forms as summarized in
Table 1), we have demonstrated that both the IRES and F2A
reliably co-expressed the concatenated proteins. However, unlike
the F2A, the IRES consistently yielded a lower expression level of
the downstream protein regardless of the locus. We have also shown
that the EGFP reporter protein, but not the Cre or the TFs, may
substantially hinder the ‘skipping’ function of F2A in the
polyproteins. Hence, it is vital for in vivo studies requiring tagging
of endogenous genes with reporter proteins in multicistronic vectors
to either explorethe use of other reporter proteins when F2Ais used
or to assess other 2A peptides for their efficacy when an EGFP
reporter protein is utilized.
Results
Sox9
IE vs. Sox9
FE mice
To compare the co-expression efficiency of the widely-used
EMCV IRES with the emerging alternative – 2A peptide from
FMDV (F2A) – in gene-targeted mice, we inserted either IRES-
EGFP or F2A-EGFP at the 39 end of the Sox9 locus (as shown in
Fig. 1A). Sox9, a HMG-box-containing transcription factor critical
in driving chondrogenesis in embryonic skeletal development
[23,24,25], was chosen for this comparison because of its high
expression level in the mouse embryos, starting at E8.5 [26],
facilitating visualization and experimentation. To eliminate any
possible adverse effects of the 2A peptide residue (23 amino acids) at
the C-terminal end of Sox9, a furin protease recognition site
(RAKR) was included right after Sox9 which trims the residual 2A
peptide from the upstream protein. This would leave only two extra
amino acids (arginine and alanine) at the C-terminus of Sox9 [2]. In
addition,a Gly-Ser-Gly(GSG)spacerwasadded justbeforetheF2A
sequence in order to enhance the translational ‘skipping’ [3,27].
EGFP efficacy assessed by fluorescence intensity and flow
cytometry
E12.5 embryos were harvested from the two mouse lines on the
same day and examined under a fluorescence microscope. While
both the homozygous Sox9
IE/IE and Sox9
FE/FE mouse embryos
expressed EGFP appropriately in the Sox9 expression domains
such as the vertebral column and limbs [26], the overall intensity
of fluorescence was distinctly higher in the Sox9
FE/FE mouse
embryos (Fig. 2A). The embryos were dissociated into single cells
and a further analysis of EGFP expression by FACSARIA Cell
Sorter substantiated the intensities. The mean overall EGFP
fluorescence of the Sox9
FE/FE embryos (84579.4862822.09; n=4)
was 6.09-fold higher (p,0.0001) than that of the Sox9
IE/IE
embryos (13880.0461015.55; n=8) (Fig. 2B, Table 2 and S1).
Stoichiometric protein expression assessed by Western
blot
To study the in vivo stoichiometric protein expression of Sox9
and EGFP, cell lysates from E12.5 Sox9
IE/IE and Sox9
FE/FE
Table 1. Mouse genotype nomenclature.
Mouse Genotype
Abbreviated
Name
Alternative
Name Neo EGFP Cre
Sox9
IRES-EGFP Sox9
IE Sox9
tm1.Tlu No Yes No
Sox9
F2A-EGFP Sox9
FE Sox9
tm2.Tlu No Yes No
FLAG3-Bapx1
F2A-EGFP FLAG3-Bapx1
FE Bapx1
tm2.Tlu No Yes No
Bapx1
IRES-Cre-IRES-EGFP Bapx1
ICIE Bapx1
tm3.Tlu No Yes Yes
Bapx1
F2A-Cre-F2A-EGFP Bapx1
FCFE Bapx1
tm4.Tlu No Yes Yes
Bapx1
EGFP Bapx1
EGFP Bapx1
tm5.Tlu No Yes No
Neo – neomycin resistance gene; EGFP – enhanced green fluorescent protein; Cre –
Cre recombinase.
doi:10.1371/journal.pone.0028885.t001
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and anti-Sox9 antibodies (Fig. 2C). The amount of EGFP in
the IRES embryos was slightly less than that in the F2A
embryos in spite of the equal loading of both the cell lysates as
detected by the anti-histone antibody (Fig. 2C and Table S3).
Based on our densitometric analysis, there was also 42.2%
Sox9-EGFP fusion protein detected by the anti-Sox9 antibody
in the F2A embryos (Fig. 2C and Table S3). However, this
fusion protein was not detected by the anti-GFP antibody,
possibly owing to its lower sensitivity compared to the anti-
Sox9 antibody. We also identified a band slightly higher than
the predicted 64 kD size for Sox9 (Sox9-2A) in the F2A embryo
lysate which indicated that the RAKR protease site failed to
induce cleavage of the residual 2A peptide from the upstream
Sox9 (Fig. 2C).
‘Skipping’ inefficiency is not locus-dependent as revealed
by FLAG3-Bapx1
FE mice
To investigate if the ‘skipping’ efficiency was dependent on the
upstream gene, we analyzed another mouse line in which F2A-
EGFP was inserted at the C-terminus of Bapx1 (Fig. 1B). Murine
Bapx1 (Nkx3.2) is a member of the NK homeobox gene family and
due to prior knowledge of its confined and specific expression
domains in cartilaginous tissues of the limbs and vertebral column
during embryogenesis [28,29], it was selected as an alternative
upstream gene to supplement the study. Unlike Sox9, Bapx1
protein is not as abundantly expressed during embryonic
development [29] and cannot be easily detected on WB.
Therefore, a triple FLAG tag (24 bp) was added at the N-terminus
of Bapx1 (FLAG3-Bapx1
FE, Fig. 1B) to allow enrichment of Bapx1
protein by affinity purification. We performed one round of
Figure 1. General gene targeting strategy for the Sox9 and Bapx1 loci. All exons are depicted as black boxes; intronic sequences as black solid
lines and untranslated regions (UTRs) as open boxes. (A) The IRES-EGFP-FRT-Neo-FRT and the F2A-EGFP-FRT-Neo-FRT cassettes were inserted in the
39UTR or just before the stop codon of the Sox9 locus for Sox9
IE (left) and Sox9
FE (right) respectively. (B) Top left: FLAG3-Bapx1
FE, triple tandem repeats
of FLAG-epitope tag and F2A-EGFP-FRT-Neo-FRT were inserted at the N-terminus of Bapx1 just after the ATG translational start site and the C-terminus
just before the stop codon respectively; top right: Bapx1
EGFP, EGFP-FRT-Neo-FRT cassette was inserted just after the ATG translational start site of
Bapx1 with a deletion of the first 30 amino acids of Bapx1 exon1, bottom left: Bapx1
ICIE, IRES-Cre-IRES-EGFP-FRT-Neo-FRT cassette inserted in the 39UTR
at Bapx1 locus; bottom right: Bapx1
FCFE, F2A-Cre-F2A-EGFP-FRT-Neo-FRT cassette was inserted just before the stop codon. F2A, 2A peptide sequence
from foot-and-mouth disease virus; EGFP, enhanced green fluorescent protein; FRT, Flp recombinase recognition target; Neo, neomycin; IRES, internal
ribosome entry site sequence; Cre, Cre recombinase.
doi:10.1371/journal.pone.0028885.g001
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IE/IE and Sox9
FE/FE embryos based on EGFP intensity and Western blotting. (A) Left panel: white light
images of E12.5 Sox9
IE/IE and Sox9
FE/FE embryos; right panel: same embryos imaged by fluorescence microscopy showed a higher EGFP fluorescence in
the Sox9
FE/FE embryo compared to the Sox9
IE/IE embryo, with EGFP expression in Sox9-specific domains in both. (B) Mean overall EGFP fluorescence of
E12.5 Sox9
IE/IE (13880.0461015.55; n=8) and Sox9
FE/FE (84579.4862822.09; n=4) embryos analyzed by flow cytometry. Overall EGFP fluorescence was
calculated by multiplying the MFI and percentage of EGFP-positive cells. Two-tailed Student’s T test, ***p,0.0001. (C) Western blot analysis of E12.5
Sox9
IE/IE and Sox9
FE/FE embryo lysates, resolved on SDS-polyacrylamide gel electrophoresis (SDS-PAGE) gels and immunoblotted with anti-Sox9 (upper
panel) and anti-GFP (middle panel) antibodies. In the upper panel, Sox9-EGFP fusion protein and Sox9-2A (2A - residual 23 amino acids of F2A) was
only detected in the Sox9
FE/FE embryo lysate, but not in the CD-1 WT or Sox9
IE/IE embryo lysates. Middle panel: Sox9-EGFP fusion protein was not
detected in the Sox9
FE/FE embryos but EGFP was detected in both the Sox9
IE/IE and Sox9
FE/FE lysates at predicted molecular weight. CD-1 WT lysate
served as negative control for EGFP. Bottom panel: immunoblotting with anti-histone antibody showed equal loading. WT – wild-type.
doi:10.1371/journal.pone.0028885.g002
Table 2. Fold change of the overall EGFP fluorescence and the p-value.
X Y Fold change of mean overall EGFP fluorescence(
X/Y) p-value
Sox9
FE/FE Sox9
IE/IE 6.09 4.70E-11
Bapx1
EGFP/EGFP Bapx1
FCFE/FCFE 1.46 2.92E-02
Bapx1
EGFP/EGFP Bapx1
ICIE/ICIE 3.11 2.33E-07
Bapx1
FCFE/FCFE Bapx1
ICIE/ICIE 2.13 3.27E-03
EGFP – Enhanced green fluorescence protein; Overall EGFP fluorescence was calculated by multiplying MFI and percentage of EGFP
+ cells.
doi:10.1371/journal.pone.0028885.t002
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FE mouse embryos
with anti-FLAG antibodies prior to WB detection with anti-Bapx1
antibody. We noted a similar degree of ‘skipping’ deficiency in the
FLAG3-Bapx1
FE mice as revealed by the amount of Bapx1-EGFP
fusion protein (49.4%) detected (Table S3). Hence, despite
targeting a different locus, we still observed a high percentage of
fusion protein (Fig. 3).
Bapx1
ICIE vs. Bapx1
FCFE mice
To further explore if the ‘skipping’ efficiency was dependent on
the upstream gene or the downstream EGFP reporter, the Cre
recombinase gene was appended in the second position, between
Bapx1 and EGFP, to generate a tricistronic knock-in mouse line
(Bapx1
FCFE) (Fig. 1B). We also generated a Bapx1
ICIE mouse line in
parallel to complete our in vivo evaluation of multicistronic co-
expression efficacy and efficiency of the IRES and F2A sequences
(Fig. 1B). The activity and expression of each of the proteins (Cre,
EGFP and Bapx1) were analyzed by X-gal staining, fluorescence
microscopy, flow cytometry and WB of developing mouse embryos
(Figs. 4, 5, 6 and 7).
Activity and spatio-temporal expression of Cre assessed
by X-gal staining
To assess the recombinase activity of Cre, the ROSA26
conditional reporter mice (ROSA26R, stock number 003309,
JAXH) were first intercrossed with Bapx1
ICIE and Bapx1
FCFE mice
to generate embryos heterozygous for both alleles. The floxed
translation-stop sequence in the Rosa26R allele recombines in the
presence of Cre recombinase and lacZ gene expression is
subsequently activated and restricted to the Cre-expressing cells
and their progeny [30].
In our study, Cre-mediated recombination of the ROSA26R
allele in both the Bapx1
ICIE;Rosa26R and Bapx1
FCFE;Rosa26R mice was
apparent at E9.5 in the cephalic mesenchyme, somites and
splanchnic mesoderm [31]. At E12.5, strong X-gal staining was
observed in the expected regions of the cartilage anlagen of the
axial and appendicular skeleton as well as the gut mesoderm of
both the IRES-Cre and F2A-Cre mice (Fig. 4a–c). Transverse
sections of E11.5 embryos displaying X-gal staining that was
confined to the mesenchyme of the midgut further demonstrated
the tissue-specificity of the Cre recombinase activity (Fig. 4d–f). In
summary, the Cre in both the IRES and F2A mice was active and
functional in the known Bapx1 expression domains as revealed by
the X-gal staining.
Functional analysis of EGFP by fluorescence intensity and
flow cytometry
E12.5 embryos from Bapx1
ICIE/ICIE and Bapx1
FCFE/FCFE mouse
lines were harvested on the same day and green fluorescence of
homozygous embryos was detected by fluorescence microscopy.
Fluorescence in the Bapx1
ICIE/ICIE embryos was observed to be
slightly weaker than that in the Bapx1
FCFE/FCFE embryos (Fig. 5C).
The mean overall EGFP fluorescence level for the Bapx1
FCFE/FCFE
embryos (2856.746387.58; n=11) was 2.13-fold higher (p,0.05)
than that in the Bapx1
ICIE/ICIE embryos (1338.136137.83; n=9)
(Fig. 6 and Table 2 and S2).
To determine which of the embryos recapitulate the endoge-
nous Bapx1 expression level, we analyzed another construct,
Bapx1
EGFP, where EGFP was inserted right after the translational
start site so that it was under the direct control of the Bapx1
promoter without being linked to any 2A or IRES sequence
(Fig. 1B). Based on our expression analysis and chromatin
immunoprecipitation (ChIP)-Seq analysis (data not shown), we
could exclude a negative feedback autoregulation for Bapx1 as
there was no up-regulation of Bapx1 transcripts in the Bapx1
null
embryos. Therefore, the EGFP protein expression of the
Bapx1
EGFP/EGFP embryos should represent the endogenous levels
of Bapx1 protein. For this reason, the overall EGFP fluorescence
levels of the Bapx1
ICIE/ICIE and Bapx1
FCFE/FCFE embryos were
compared with that of the Bapx1
EGFP/EGFP embryos. A much
higher level of green fluorescence was seen in the E12.5
Bapx1
EGFP/EGFP embryos in contrast to the Bapx1
ICIE/ICIE embryos
of the same stage (Fig. 5A). Flow cytometry analysis also showed a
3.11-fold greater (p,0.0001) mean overall EGFP fluorescence
levels of the Bapx1
EGFP/EGFP embryos (4159.566297.81; n=7)
compared to that of the Bapx1
ICIE/ICIE embryos (Fig. 6 and Table 2
and S2). Likewise, a comparison of the Bapx1
EGFP/EGFP embryos
with the Bapx1
FCFE/FCFE embryos revealed a higher mean overall
EGFP fluorescence level in the former by 1.46-fold (p,0.05)
evident from fluorescence microscopy and FACS analysis (Figs. 5B,
6, Table 2 and S2). Nevertheless, this deviation from the
endogenous Bapx1 protein expression level was 36.5% less than
that of the Bapx1
ICIE/ICIE embryos (Table S2 legend). Thus, the
EGFP protein expression in the Bapx1
FCFE/FCFE embryos more
closely resembled the endogenous Bapx1 protein expression level
than that of the Bapx1
ICIE/ICIE embryos.
Co-translational 2A ‘skipping’ efficiency in the Bapx1
FCFE
mice
We analyzed Bapx1, Cre recombinase and EGFP protein
expression by Western blotting using cell lysates from enriched
tissues (limbs and vertebral column) of homozygous E12.5
Bapx1
ICIE/ICIE and Bapx1
FCFE/FCFE embryos. Protein extract from
wild-type (WT) CD-1 mouse embryos was included as a negative
control for Cre recombinase and EGFP proteins. Migrations of
Cre (38 kD) and EGFP (27 kD) proteins from the Bapx1
ICIE/ICIE
embryos on the SDS-PAGE gel were consistent with their
predicted molecular weights as detected by anti-Cre and anti-
GFP antibodies (Fig. 7).
We then examined the efficiency of co-translational 2A
‘skipping’ in the Bapx1
FCFE/FCFE mice. Interestingly, the ‘skipping’
at the F2A between Bapx1 and Cre was found to be .99% efficient
as only an insignificant amount of Bapx1-Cre and Bapx1-Cre-
Figure 3. Western blot analysis of F2A efficiency at the Bapx1
locus. Cell lysates from ten E12.5 FLAG3-Bapx1
FE embryos were affinity
purified using anti-FLAG antibody-conjugated beads. Protein fractions
from total lysate, first and last wash, eluate and boiled beads were
subjected to SDS-PAGE. Immunoblotting by anti-Bapx1 antibody
detected FLAG3-Bapx1-EGFP fusion protein and discrete FLAG3-Bapx1
protein only in the eluate. L, total cell lysate; U, unbound protein (first
wash); W, wash (last wash); E, eluate; B, boiled beads.
doi:10.1371/journal.pone.0028885.g003
IRES and F2A in Stable Mouse Lines
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(Fig. 7 top panel). Then again, the ‘skipping’ at the second F2A,
between Cre and EGFP, was highly inefficient yielding 55.3% and
62.2% of Cre-EGFP fusion protein as identified by both the anti-
Cre and anti-GFP antibodies respectively. Bapx1-Cre-EGFP,
however, was not detected by the anti-GFP antibody which, as
mentioned earlier, could be attributed to its lower sensitivity (Fig. 7
and Table S3).
Lastly, similar to the observations for Sox9 (Sox9-2A), we also
detected a slightly higher molecular weight Cre protein (Cre-2A)
in the Bapx1
FCFE/FCFE lysate, indicating that the RAKR protease
motif upstream of the second F2A, failed to induce complete
cleavage of the residual F2A peptide at the C-terminus of Cre
(Fig. 7). As the available anti-Bapx1 antibody was not sensitive
enough to detect Bapx1 from unpurified embryo lysates, we could
not evaluate if the RAKR preceding the first F2A was functional
(data not shown).
Discussion
The development of technologies such as FACS to isolate cells,
and expression profiling, RNA-Seq and ChIP-Seq for genome-
wide analyses of gene functions have brought about an immense
need to co-express genes with reporter proteins for cell tracking
and high-purity enrichment. Furthermore, the employment of Cre
recombinase to achieve conditional gene ablation has become a
prevalent method to study genes that cause prenatal lethality
[32,33,34]. Using the IRES and/or the 2A peptide to generate
such multicistronic vectors has become the norm to tag
endogenous genes with reporter or recombinase proteins
[5,17,33,35,36]. Hence, we have adopted these two strategies for
our study to assess their applicability in an in vivo scenario,
comparing the IRES and the F2A peptide for the first time in
stable mouse lines showing locus-specific expression of the
transgenes.
It is appropriate to study TFs as a proof-of-principle as there is a
widespread interest in TFs owing to their key roles as regulatory
molecules and also their importance in reprogramming of somatic
cells to iPS cells [7]. Sox9, in particular, was of interest as its
functions are well-studied and it is expressed at an early embryonic
stage which made it technically feasible for experimentation [26].
Similarly, Bapx1 was chosen as the alternative locus of comparison
owing to its similar tissue expression domains as Sox9 and its
appearance early in development [28].
From the EGFP fluorescence levels seen in the fluorescence
microscopy and flow cytometry of the Sox9- and Bapx1-targeted
embryos, we observed that the F2A-mediated multicistronic
constructs consistently produced higher EGFP levels than the
corresponding IRES-constructs. Furthermore, when compared
with the Bapx1
EGFP/EGFP embryos, the Bapx1
FCFE/FCFE embryos
had a near stoichiometric protein expression of EGFP and Bapx1.
Conversely, Bapx1
ICIE/ICIE showed a greater deviation from the
endogenous level of Bapx1 expression. These results conform to the
known properties of the IRES producing lower amounts of the
downstream protein in relation to the upstream protein.
Nevertheless, both the F2A and the IRES co-expressed functional
proteins at acceptable levels in the Sox9 and the Bapx1 loci.
Contrary to the conclusion of Lorens et al 2004 [37] who
attributed the complete absence of fusion protein to the inclusion
of the GSG linker, we observed a substantial amount of fusion
protein despite its addition preceding the F2A sequence. In fact,
other studies [16,38] that used the GSG linker sequence still
showed an inefficient ‘skipping’ which is consistent with our
results. In addition, the RAKR motif used to remove the residual
2A peptide from the upstream protein also proved ineffective in
our study, as shown by the presence of Sox9-2A and Cre-2A
proteins. This result clearly differs from what was reported by
Fang et al 2005 [2]. To our knowledge no one has used both the
GSG linker and the RAKR motif in conjunction. Hence, we
believe unknown effects of this partnership might have led to the
Figure 4. Functional analysis of Cre activity in the Bapx1
ICIE;Rosa26R and Bapx1
FCFE;Rosa26R mice. (a–c) Whole-mount E12.5 Bapx1
ICIE;Rosa26R and
Bapx1
FCFE;Rosa26R embryos stained with X-gal showing b-galactosidase activity in the correct anatomical context of Bapx1. (d–f) Transverse sections of
E11.5 embryos confirmed X-gal stained cells in the mesenchymal cells of the midgut and not in the endothelium. MC, Meckel’s cartilage; LM, limb
mesenchyme; VC, vertebral column; R, ribs; M, mesenchyme; E, endothelium.
doi:10.1371/journal.pone.0028885.g004
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linker sequences and the furin motif are not fool-proof solutions for
inefficient ‘skipping’ and the removal of residual peptides
respectively.
The presence of 42.2% Sox9-EGFP fusion protein led us to
investigate further if the upstream protein in context might hinder
the ‘skipping’ mechanism of the F2A peptide. Therefore, we
analyzed the F2A ‘skipping’ efficiency in a construct with a
different upstream protein (Bapx1).
To avoid confounding our results with potential stage-specific
alterations to the ‘skipping’ function, we kept the developmental
stage of interest (E12.5) constant in our study. As Bapx1 is a
moderately expressed protein and the anti-Bapx1 antibody was
not adequately sensitive, we only managed to detect it from the
FLAG3-Bapx1
FE embryo lysates after purification. Surprisingly,
despite changing the upstream protein in context (FLAG3-Bapx1
FE),
we still observed 49.4% FLAG3-Bapx1-EGFP fusion protein thus
validating our conclusions drawn from the Sox9
FE construct.
Hence, we can be more confident that neither the upstream
protein nor the locus was responsible for the ‘skipping’ inefficiency
of the F2A. This was further corroborated by the results from the
Bapx1
FCFE/FCFE, whereby Bapx1 was shown not to affect the
‘skipping’ process in the first F2A due to the negligible amounts of
Bapx1-Cre fusion protein detected. This also implied that Cre
does not have an adverse effect on the 2A-mechanism. However,
even while maintaining the locus but changing the gene upstream
of EGFP, from Bapx1 to Cre in Bapx1
FCFE/FCFE, we still saw 55.3%
and 62.2% fusion protein (Cre-EGFP) relative to Cre and EGFP
proteins respectively. This indicated that the ‘skipping’ at the
second F2A was highly inefficient. Since EGFP was the common
Figure 5. EGFP expression mediated by IRES and F2A at the Bapx1 locus. Homozygous E12.5 Bapx1
EGFP/EGFP, Bapx1
ICIE/ICIE and Bapx1
FCFE/FCFE
embryos imaged under white light (left panel) and fluorescence microscope (right panel). EGFP expression recapitulates Bapx1 expression domains in
all three Bapx1-targeted mouse lines. (a) In Bapx1
EGFP/EGFP vs. Bapx1
ICIE/ICIE, the former clearly showed brighter fluorescence. (b) In Bapx1
EGFP/EGFP vs.
Bapx1
FCFE/FCFE, both had comparable fluorescence intensities. (c) In Bapx1
ICIE/ICIE vs. Bapx1
FCFE/FCFE, the latter displayed a slightly higher EGFP
fluorescence.
doi:10.1371/journal.pone.0028885.g005
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causal agent behind the inefficient ‘skipping’ mechanism.
Upon scrutiny of prior publications which also used the F2A in
their constructs, fusion proteins were observed in all instances
where EGFP was the concatenated protein, in both in vitro
translation or in vivo cell culture and animal models [6,16,17,39].
Besides, in Furler et al 2001 [17] and Kim et al 2011 [16], a
significant degree of ‘skipping’ inefficiency was observed even
when EGFP was upstream of the F2A sequence, proving that what
was observed in our study was not a positional effect [40]. This
strongly supports our hypothesis that EGFP may have an
inhibitory effect on the F2A-mediated ‘skipping’ mechanism, the
basis of which is yet unclear. In their recent publication, Felipe et al
2010 [19] proposed that the inhibition of the 2A process might be
dependent on the upstream nascent protein. On the other hand,
based on our results, it is evident that there is much more to the
mechanism of the 2A-mediated ‘skipping’ which remains obscure
to date. Structural investigations and partial deletion experiments
of EGFP in bicistronic constructs, similar to what Felipe et al 2010
[19] had performed in their investigation, may help to reveal the
mechanism.
In our study, we have clearly demonstrated that the F2A
peptide and the IRES elements are functional in multicistronic
constructs when expressed in a stable mouse line. The F2A
maintains a more reliable expression level of the appended
downstream cistron than the IRES. Additionally, our vital finding
that the predominantly-used EGFP reporter likely hinders the
‘skipping’ mechanism of the F2A peptide serves as a caution to
researchers who utilize it in their F2A-based multicistronic
constructs. Ultimately, the 2A peptide remains unchallenged as the
ideal strategy for co-expressing multiple proteins in vivo and
researchers often opt for EGFP as the reporter in mouse models
because it is highly photostable and one of the brightest fluorescent
proteins [20]. The presence of a fusion protein from inefficient
ribosomal ‘skipping’ has often been ignored, but it is imperative
that we do not overlook the implications of such a fusion protein in
an in vivo system. As there are increasing numbers of studies
employing expression profiling and next-generation sequencing to
elucidate gene regulation at cellular resolution, it is important to
note that even minute amounts of fusion protein may alter the
genomic architecture and lead to a false representation of
transcripts and binding sites. Therefore, we ought to employ
strategies that will give us equivalent expression levels on top of
producing discrete translational products. Hence, to alleviate some
of the issues, other 2A peptides (E2A, P2A, T2A) could be verified
for their compatibility with EGFP. Furthermore, other reporter
proteins could be explored for use in the F2A-based constructs.
While several others propose using GSG linkers and longer
versions of the F2A to counter the ‘skipping’ problem [15,19,37],
we believe these are not fail-safe solutions, and should be assessed
carefully for every protein in context.
Figure 6. Mean overall EGFP fluorescence of E12.5 Bapx1
EGFP/EGFP,
Bapx1
FCFE/FCFE and Bapx1
ICIE/ICIE embryos. Mean overall EGFP fluo-
rescence of E12.5 Bapx1
EGFP/EGFP (4159.566297.81; n=7), Bapx1
FCFE/FCFE
(2856.746387.58; n=11) and Bapx1
ICIE/ICIE (1338.136137.83; n=9)
embryos analyzed by flow cytometry. Overall EGFP fluorescence was
calculated by multiplying MFI and percentage of EGFP-positive cells.
Two-tailed Student’s T test, *p,0.05, ***p,0.0001.
doi:10.1371/journal.pone.0028885.g006
Figure 7. Efficiency of the IRES and the F2A at the Bapx1 locus
assessed by Western blotting. Lysates from E12.5 CD-1 WT,
Bapx1
ICIE/ICIE and Bapx1
FCFE/FCFE embryos were resolved on SDS-PAGE
and immunoblotted with anti-Cre (top panel) and anti-GFP (middle
panel) antibodies. Top panel: Faint bands were detected for Bapx1-Cre-
EGFP and Bapx1-Cre fusion proteins at the predicted molecular weights in
Bapx1
FCFE/FCFE; significant amounts of Cre-EGFP fusion proteins and Cre-2A
(2A – residual 23 amino acids of F2A) were also detected. No fusion proteins
or Cre-2A, but Cre (38 kD), were detected in Bapx1
ICIE/ICIE.M i d d l ep a n e l :C r e -
EGFP but not Bapx1-Cre-EGFP fusion protein was detected in Bapx1
FCFE/FCFE;
EGFP of predicted molecular weight was detected in both Bapx1
ICIE/ICIE and
Bapx1
FCFE/FCFE, but not in the negative control (CD-1 WT). Bottom panel:
immunoblotting with anti-histone antibody showed equal loading.
doi:10.1371/journal.pone.0028885.g007
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Ethics Statement
All animal procedures were performed according to the
Singapore A*STAR Biopolis Biological Resource Center (BRC)
Institutional Animal Care and Use Committee (IACUC) guide-
lines and the IACUC protocols employed were reviewed and
approved by the aforementioned committee before any animal
procedures were undertaken for the study described here (IACUC
Protocol No: 080348 and 080377).
Bacterial Artificial Chromosome (BAC) modification and
Bapx1 targeting
Murine BAC clone RP24-148P5 derived from the C57BL/6J
mouse strain, containing over 160 kb of genomic DNA flanking
the Bapx1 gene was obtained from the BACPAC Resources Centre
at Children’s Hospital Oakland Research Institute (CHORI). The
BAC was modified by homologous recombination using the Quick
and Easy BAC modification kit (Gene Bridges) following the
manufacturer’s instruction. The IRES-Cre-IRES-EGFP-FRT-PGK-
gb2-Neo-FRT cassette was inserted into the 39UTR of Bapx1,
whereas the F2A-Cre-F2A-EGFP-FRT-PGK-gb2-Neo-FRT cassette
was inserted immediately before the translational stop codon of
Bapx1 (Fig. 1B). A 20.6 kb fragment (IRES clone) and a 19.6 kb
fragment (F2A clone) spanning the whole coding region of Bapx1
were then subcloned into a minimal vector using the BAC
subcloning kit (Gene Bridges). The resulting targeting vectors were
linearized and electroporated into V6.4 mouse embryonic stem
cells (ESC) [41], to generate Bapx1
ICIE and Bapx1
FCFE ESC clones.
The gene targeting events were confirmed by Southern blotting
and the correctly targeted ESC clones with a normal karyotype
were subsequently microinjected into 2–8 cell stage embryos
isolated from C57BL/6J mice to generate germ-line transmitting
chimeric mice [42]. Subsequent heterozygous progeny was bred to
the ROSA-Flpe mice (Stock number 3946, JAXH) for the excision of
the FRT-flanked neomycin cassette in the targeted Bapx1 allele.
Details of the construct design for Bapx1
ICIE and Bapx1
FCFE have
been described in [31] while those for Sox9
IE, Sox9
FE, FLAG3-
Bapx1
FE and Bapx1
EGFP will be described in another manuscript
that is in preparation.
Southern blotting and PCR genotyping
Genomic DNA was extracted from ESC cells or tail biopsies
using phenol-chloroform following overnight Proteinase K diges-
tion (Sigma, final concentration of 0.1 mg/ml and 0.5 mg/ml for
cells and tails respectively) at 55uC. DNA (10 ug) digested with the
appropriate restriction enzymes was separated on 0.8% agarose
gels, denatured with 0.5 M NaOH and transferred to positively-
charged nylon membranes (Amersham Hybond-N+). Membranes
were hybridized overnight with the appropriate Digoxigenin
(DIG)-labeled probes (Roche PCR DIG Probe Synthesis Kit) at
42uC following a 4-hour (h) prehybridization (Roche DIG Easy
Hyb). The following day, membranes were washed [26SSC for
10 minutes (mins) at room temperature (RT) then 0.56 SSC,
0.1% SDS for 2615 mins at 60uC], blocked (16Roche Blocking
Reagent) and probed with anti-DIG-AP antibody (Roche) at
1:5000 dilution in 16 blocking buffer, each step for 30 mins at
RT. Membranes were washed again in 16MABT, 2615 mins at
RT, rinsed briefly in detection buffer and incubated with CSPD at
37uC for 10 mins before visualization on X-ray films. Routine
mouse genotyping was performed by PCR with the following
primer pairs and amplicon: EGFP (59 CCTACGGCGTGCA-
GTGCTTCAGC 39 and 59 CGGCGAGCTGCACGCTGCCG-
TCC 39; 345 bp); primer pair 1 (59 GACCCCAGGAGCTCTG-
CAC 39 and 59 GGGCTGAAAGGATTCTGCAC 39; WT allele:
293 bp, Bapx1
ICIE allele: 3.4 kb) and primer pair 2 (59 AAGA-
AAGTGGCCGTAAAGGTG 39 and 59 ACCCTGGATAGGT-
GTGTCAAGT 39; WT allele: 320 bp, Bapx1
FCFE allele: 2.7 kb).
Flow cytometric analysis
Mouse embryos were dissociated into single cells by repeated
pipetting in an enzymatic buffer comprising Collagenase I & II
(100 U/ml; Gibco), DNAse (50 U/ml; Sigma) and 0.05%
Trypsin (Gibco). The cells were filtered through a 100 uM
followed by a 40 uM cell strainer before centrifugation at
2000 rpm for 5 mins. The cell pellet obtained was resuspended
in 5% fetal bovine serum, 4 mM EDTA in Leibovitz’s L-15
medium for flow cytometry analysis. E12.5 CD-1 WT embryos
were used for gating. Overall EGFP fluorescence (mean
fluorescence intensity (MFI) multiplied by the percentage of
EGFP-positive cells) was measured with the FACSAria flow
cytometer (BD Biosciences) and analyzed using the FACSDiva
Version 6.1.3 software.
Statistical Evaluation
For all overall EGFP fluorescence values (MFI6percentage of
EGFP-positive cells), the mean and standard errors were
calculated using the data analysis tool (Analysis ToolPak) in
Microsoft Excel X. Student’s T-tests (two-tailed) with 95%
confidence intervals were performed for all pair-wise comparisons
to analyze the differences in the overall EGFP fluorescence levels.
Mouse crosses
The Cre-Tester line B6;129
S4-Gt(ROSA)26Sortm1Sor/J(ROSA26R) was
purchased as frozen embryos from JAXH (Stock number 003309.
Abbreviated as Rosa26R) and re-derived by the Biological Resource
Centre (A*STAR). Cre-tester mice were mated to the created mouse
lines, Bapx1
ICIE and Bapx1
FCFE for the generation of double
heterozygous embryos, Bapx1
ICIE;Rosa26R and Bapx1
FCFE;Rosa26R.E 0 . 5
was defined as the day the vaginal plug was detected. Upon Cre
recombination in Bapx1-expressing cells, lacZ gene expression
was activated and reflected by b-galactosidase activity in these
tissues.
Whole-mount X-gal staining of E11.5 and E12.5 mouse
embryos
Mouse embryos were harvested in cold Leibovitz medium and
critically staged using morphological criteria established by M.H.
Kaufmann. These embryos were fixed for 5 mins (,E12.5) or
15 mins (.E12.5) in 4% paraformaldehyde (PFA) on ice, followed
by 365 mins washes in ice-cold PBS. Embryos were left for colour
development in X-gal staining solution (2 mM MgCl2; 0.01%
deoxycholic acid; 0.02% Igepal CA-630; 0.1% (1 mg/ml) X-Gal
in DMF; 5 mM K4; 5 mM K3 in 16PBS, pH 8) at 4uC in the
dark for 48 h with agitation. Stained embryos were subsequently
rinsed and post-fixed.
Paraffin embedding and sectioning
X-gal-stained mouse embryos were post-fixed in 4% PFA at 4uC
overnight, washed with PBS, dehydrated through 50% and 70%
ethanol/PBS for 15 mins each before being placed in an
automated tissue processor (Leica TP 1020) for further dehydra-
tion through 70%, 90%, 95% ethanol/PBS and 100% ethanol,
followed by Histo-clearH (substituted for xylene) and paraffin
embedding. Paraffin-embedded embryos were sectioned at
10 microns with a Leica RM 2165 microtome. Sections were
placed on polysine-coated glass slides (Fischer-Scientific) and
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were photographed using Zeiss Axio Imager Z1 microscope.
Western blotting
Whole or dissected mouse embryos were homogenized and
protein lysates were obtained following instructions in the NE-
PERH Nuclear and Cytoplasmic Extraction Reagent kit (Thermo
Scientific). Bradford protein assay was used to measure the protein
concentrations (BioRad Cat. # 500-0205). Equal amounts of cell
lysates were loaded for each lane. Proteins were separated in
NuPAGEH 4%–12% Bis-Tris gels (Invitrogen) and transferred to a
PVDF membrane (Biorad Immun-Blot
TM) at 25 volts for 30 mins
with Biorad Trans-BlotH Semi-Dry Transfer Cell. Membranes
were blocked in 5% skimmed milk (BD Difco) in TBST for 1 h at
RT, incubated with goat anti-Sox9 (AF3075 (R&D Systems);
1:1000 dilution), rabbit anti-Bapx1 (ab56029 (Abcam); 1:2000
dilution), rabbit anti-GFP (sc-8334 (Santa Cruz); 1: 200 dilution),
rabbit anti-Cre (pRB-106C (Covance); 1:500 dilution) or rabbit
anti-Histone (ab1791 (Abcam); 1:1000 dilution) in 3% BSA in
TBST for 1 h at RT and washed in TBST for 4615 mins before
incubation with HRP-conjugated donkey anti-rabbit antibody
(NA934 (GE healthcare); 1: 10,000) or HRP-conjugated donkey
anti-goat antibody (sc2020 (Santa Cruz); 1:5000) in 3% BSA in
TBST for 1 h at RT. Membranes were then washed in TBST for
3610 mins at RT. Relevant proteins were detected with Super-
signal
TM West Pico enhanced chemiluminescence (ECL) reagents
(Thermo Scientific) and exposed onto X-ray films. Densitometric
analysis of the protein bands on the X-ray films were performed by
measuring protein band densities (OD/mm
2) using the GS-800
Calibrated Densitometer and analyzing the results using the
Quantity One 4.5.2 software. All values were normalized to their
respective histone densities.
Supporting Information
Table S1 MFI, percentage of EGFP
+ cells and overall
EGFP fluorescence of E12.5 Sox9 mouse embryos. Raw
values of MFI and percentage of EGFP
+ for each Sox9
IE/IE and
Sox9
FE/FE mouse embryo. Overall EGFP fluorescence was
calculated by multiplying MFI and percentage of EGFP
+ cells.
MFI – Mean fluorescence intensity; EGFP – Enhanced green
fluorescence protein; SE –Standard error.
(DOC)
Table S2 MFI, percentage of EGFP
+ cells and overall
EGFP fluorescence of E12.5 Bapx1 mouse embryos. Raw
values of MFI and percentage of EGFP
+ for each Bapx1
EGFP/EGFP,
Bapx1
ICIE/ICIE and Bapx1
FCFE/FCFE mouse embryo. Overall EGFP
fluorescence was calculated by multiplying MFI and percentage of
EGFP
+ cells. Percentage difference in deviation of mean overall
fluorescence from endogenous levels between F2A and IRES
Bapx1 embryos=[(A–B)2(A–C)]/A *100%=36.5%. MFI – Mean
fluorescence intensity; EGFP – Enhanced green fluorescence
protein; SE –Standard error.
(DOC)
Table S3 Densitometry analysis of the Western blots.
Raw densitometry values calculated for the protein bands in the
Western blots of figures 2D, 3 and 7. 2A - residual 23 amino acids
of F2A; EGFP – Enhanced green fluorescence protein; OD –
optical density.
(DOC)
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